Subramamyam Penubaku/ LinkedIn
Jun 4, 2026, 05:42
Subramamyam Penubaku: Early Recognition and Risk-Based Management of Acute Pulmonary Embolism
Subramamyam Penubaku, Specialist of Emergency Medicine, Assistant Professor at Government General Hospital, shared a post on LinkedIn:
“Acute Pulmonary Embolism (PE): A Time-Critical Emergency
Pulmonary embolism remains one of the most challenging diagnoses in Emergency and Critical Care Medicine. Early recognition, risk stratification, right ventricular assessment, and timely anticoagulation/reperfusion therapy can significantly improve outcomes.
This revision sheet provides a concise overview of:
- PE risk categories (A–E)
- Hemodynamic assessment and shock definitions
- Respiratory support strategies
- Advanced reperfusion therapies
- Anticoagulation and long-term management”
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 09:51Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?
-
Sep 11, 2026, 09:35Yasir Khan: Travel Related Blood Clots – What Are the Chances?
-
Sep 11, 2026, 08:02Mud Alvi: Restarting Antithrombotic Therapy After Hemorrhagic Transformation of Ischemic Stroke
-
Sep 11, 2026, 08:01Chaza Alaji: Factor X From Inherited Deficiency to Acquired Deficiency in AL Amyloidosis
-
Sep 11, 2026, 08:01Mariusz Kowalewski: Risk Stratification of Surgical Ablation During Minimally Invasive Mitral Valve Surgery for AFib
-
Sep 11, 2026, 08:00Noor Gajraj: MTHFR Helps Turn Folate, Vitamin B9, Into The Form The Body Uses
-
Sep 11, 2026, 07:59Lisa Lacy: Living With Hereditary Antithrombin Deficiency and the Constant Threat of Clotting
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD